Estrella PMP, Flores RCM

Language: Spanish
References: 12
Page: 185-188
PDF size: 179.49 Kb.

Text Extraction

No abstract.

REFERENCES

1. Cieza A, Causey K, Kamenov K, Hanson SW, Chatterji S, VosT. Global estimates of the need for rehabilitation basedon the Global Burden of Disease study 2019: a systematicanalysis for the Global Burden of Disease Study 2019.Lancet. 2021 Dec 19;396(10267):2006–17.

2. McIntyre S, Goldsmith S, Webb A, Ehlinger V, HollungSJ, McConnell K, et al. Global prevalence of cerebralpalsy: A systematic analysis. Dev Med Child Neurol. 2022Dec;64(12):1494–506.

3. García-Benítez C, Venta-Sobero JA, Hernández-Sánchez J,Navarro-Vargas JL. Consenso mexicano para la aplicación detoxina botulínica en padecimientos neurológicos. RevistaMexicana de Neurociencia. 2009;10(2):107–11.

4. Barron-Garza F, Coronado-Garza M, Gutierrez-Ramirez S,Ramos-Rincon JM, Guzman-de la Garza F, Lozano-MorantesA, Flores-Rodriguez A, Nieto-Sanjuanero A, Alvarez-Villalobos N, Flores-Villarreal M, Covarrubias-Contreras L.Incidence of Cerebral Palsy, Risk Factors, and Neuroimagingin Northeast Mexico. Pediatr Neurol. 2023 Jun;143:50-58.doi: 10.1016/j.pediatrneurol.2023.02.005.

5. Doyle LW, Anderson PJ, Battin M, Bowen JR, Brown N,Callanan C, Campbell C, Chandler S, Cheong J, DarlowB, Davis PG, DePaoli T, French N, McPhee A, Morris S,O'Callaghan M, Rieger I, Roberts G, Spittle AJ, Wolke D,Woodward LJ. Long term follow up of high risk children:who, why and how? BMC Pediatr. 2014 Nov 17;14:279.doi: 10.1186/1471-2431-14-279

6. Novak I, Morgan C, Adde L, Blackman J, Boyd RN,Brunstrom-Hernandez J, et al. Early, Accurate Diagnosis andEarly Intervention in Cerebral Palsy: Advances in Diagnosisand Treatment. JAMA Pediatr. 2017 Sep 1;171(9):897–907.

7. Shapiro SM, Riordan SM. Review of bilirubin neurotoxicityII: preventing and treating acute bilirubin encephalopathyand kernicterus spectrum disorders. Pediatr Res. 2020Jan;87(2):332-337. doi: 10.1038/s41390-019-0603-5.

8. Peyton C, Einspieler C, Fjørtoft T, Adde L, Schreiber MD,Drobyshevsky A, et al. Correlates of Normal and AbnormalGeneral Movements in Infancy and Long-Term Neurodevelopmentof Preterm Infants: Insights from FunctionalConnectivity Studies at Term Equivalence. J Clin Med Res.2020 Mar 19;9(3). http://dx.doi.org/10.3390/jcm9030834

9. Goyen TA, Morgan C, Crowle C, Hardman C, Day R, NovakI, et al. Sensitivity and specificity of general movementsassessment for detecting cerebral palsy in an Australiancontext: 2-year outcomes. J Paediatr Child Health. 2020Sep;56(9):1414–8.

10. Romeo DM, Ricci D, Brogna C, Mercuri E. Use of the HammersmithInfant Neurological Examination in infants withcerebral palsy: a critical review of the literature. Dev MedChild Neurol. 2016 Mar;58(3):240–5.

11. Morgan C, Romeo DM, Chorna O, Novak I, Galea C, DelSecco S, et al. The Pooled Diagnostic Accuracy of Neuroimaging,General Movements, and Neurological Examinationfor Diagnosing Cerebral Palsy Early in High-Risk Infants:A Case Control Study. J Clin Med Res [Internet]. 2019Nov 5;8(11). Available from: http://dx.doi.org/10.3390/jcm8111879

12. Benini R, Dagenais L, Shevell MI, Registre de la ParalysieCérébrale au Québec (Québec Cerebral Palsy Registry) Consortium.Normal imaging in patients with cerebral palsy:what does it tell us? J Pediatr. 2013 Feb;162(2):369–74.e1.